Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma
- PMID: 21839963
- DOI: 10.1016/j.wneu.2011.02.005
Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma
Abstract
Objective: To compare intraoperative magnetic resonance imaging (MRI)-guided resection with resection guided by 5-aminolevulinic acid (5-ALA)-induced fluorescence in patients with gliomas and to evaluate the impact of intraoperative MRI in glioma surgery.
Methods: From January 2005 to February 2009, 33 patients with gliomas (6 with World Health Organization [WHO] grade II, 7 with WHO grade III, 20 with WHO grade IV) who underwent craniotomy with neuronavigation and received 5-ALA by the same neurosurgeon were investigated retrospectively. In 19 patients, operations were performed using a combination of 5-ALA with intraoperative 1.5-T MRI. All patients were subjected to postoperative 1.5-T MRI to confirm the extent of resection.
Results: Of 33 patients with gliomas, 21 (4 with WHO grade III and 17 with WHO grade IV) were 5-ALA-induced fluorescence-positive (5-ALA (+)). Surgery with intraoperative MRI was performed in 10 of the 21 patients, and the average resection rate was 92.6%. The average resection rate of patients who underwent surgery without intraoperative MRI was 91.8%. 5-ALA-induced fluorescence was not detected in 12 patients (6 with WHO grade II, 3 with WHO grade III, and 3 with WHO grade IV) with gliomas. Surgery with intraoperative MRI was performed in 9 of 12 patients, and the average resection rate was 89.2%. The average resection rate of patients who underwent surgery without intraoperative MRI was 68.7%. Intraoperative MRI-guided tumor resection resulted in a better resection rate in patients with 5-ALA-induced fluorescence-negative (5-ALA (-)) gliomas than in patients with 5-ALA (+) gliomas (20.5% vs 0.8%).
Conclusions: Intraoperative MRI-guided resection is a powerful tool to treat 5-ALA (-) gliomas (mostly low grade), and 5-ALA is useful for high-grade gliomas. The combination of intraoperative MRI and 5-ALA has a synergistic effect in glioma surgery. Additionally, precise tumor grading in preoperative imaging studies can be difficult. Surgery for gliomas should be performed using both 5-ALA-induced fluorescence and intraoperative MRI-guided resection.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.World Neurosurg. 2014 Jul-Aug;82(1-2):e277-9. doi: 10.1016/j.wneu.2013.07.002. Epub 2013 Jul 16. World Neurosurg. 2014. PMID: 23871813
-
Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients.J Neurooncol. 2015 Mar;122(1):151-60. doi: 10.1007/s11060-014-1694-9. Epub 2015 Jan 4. J Neurooncol. 2015. PMID: 25557106
-
Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.J Neurosurg. 2011 Mar;114(3):613-23. doi: 10.3171/2010.3.JNS097. Epub 2010 Apr 16. J Neurosurg. 2011. PMID: 20397896 Clinical Trial.
-
Intraoperative fluorescence-guided resection of high-grade gliomas: a comparison of the present techniques and evolution of future strategies.World Neurosurg. 2014 Jul-Aug;82(1-2):175-85. doi: 10.1016/j.wneu.2013.06.014. Epub 2013 Jul 9. World Neurosurg. 2014. PMID: 23851210 Review.
-
Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies.J Clin Neurosci. 2012 Nov;19(11):1471-4. doi: 10.1016/j.jocn.2012.03.009. Epub 2012 Sep 5. J Clin Neurosci. 2012. PMID: 22959448 Review.
Cited by
-
Spontaneous intracerebral haemorrhage secondary to 5-ALA-induced thrombocytopaenia in a paediatric patient: case report and literature review.Childs Nerv Syst. 2023 Apr;39(4):1051-1058. doi: 10.1007/s00381-023-05846-y. Epub 2023 Jan 20. Childs Nerv Syst. 2023. PMID: 36662275 Free PMC article. Review.
-
Surgical Treatment of Glioblastoma: State-of-the-Art and Future Trends.J Clin Med. 2022 Sep 13;11(18):5354. doi: 10.3390/jcm11185354. J Clin Med. 2022. PMID: 36143001 Free PMC article. Review.
-
Toward Quantitative Neurosurgical Guidance With High-Resolution Microscopy of 5-Aminolevulinic Acid-Induced Protoporphyrin IX.Front Oncol. 2019 Jul 3;9:592. doi: 10.3389/fonc.2019.00592. eCollection 2019. Front Oncol. 2019. PMID: 31334117 Free PMC article.
-
The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.J Neurooncol. 2019 Feb;141(3):507-515. doi: 10.1007/s11060-018-03061-3. Epub 2018 Dec 1. J Neurooncol. 2019. PMID: 30506501
-
A preclinical study of a novel dual-modality contrast agent in rodent models.Front Bioeng Biotechnol. 2025 Mar 20;13:1557772. doi: 10.3389/fbioe.2025.1557772. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40182986 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical